HOME >> BIOLOGY >> NEWS
UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment

(Santa Barbara, Calif.) The University of California, Santa Barbara announced today that it has donated all rights to a patent that covers the novel use of an established class of cardiovascular medicines as a potential new drug against a global parasitic disease. The Institute for OneWorld Health, a nonprofit pharmaceutical company based in San Francisco, will use the UCSB discovery and the wealth of data associated with the medicines to accelerate drug development for treatment of schistosomiasis.

Two UCSB researchers discovered that calcium channel blockers may prove to be an inexpensive alternative for controlling schistosome infection, a serious global health problem that afflicts more than 200 million people annually in developing nations. An estimated 200,000 people, many of them older children, die every year from schistosomiasis. Many more suffer chronic damage to vital organs, including the liver and bladder.

The inventors are Mark Walter, a research biologist, and Armand Kuris, professor of biology.

"Calcium channel blockers look very promising for the treatment of schistosomiasis, which is a devastating disease," said Kuris, an expert in parasitology and associate provost of the College of Creative Studies. Physicians routinely prescribe calcium channel blockers to treat high blood pressure, correct abnormal heart rhythms, treat panic attacks and bipolar disorder, and prevent migraine headaches.

"We know that the drugs are safe for people," said Kuris. "They are available, and not terribly expensive. For a tropical disease that is very, very important. We are gratified by OneWorld Health's interest in our discovery, and confident in its ability to develop this inexpensive treatment for schistosomiasis for children in rural villages throughout the world."

OneWorld Health partners with pharmaceutical and biotechnology companies, universities, government agencies, and global health advocates to develop comp
'"/>


24-Feb-2004


Page: 1 2 3

Related biology news :

1. UC Santa Barbara discovers cell survival gene may lead to treatments for degenerative diseases
2. Chemical society convenes regional meeting in Santa Barbara, October 28-31
3. Webcast will ensure broad public access to the UC Santa Cruz Public Forum on Human Genome Research
4. UC Santa Cruz Public Forum on the Human Genome
5. Coastal research project at UC Santa Cruz receives major boost in funding
6. UC Davis, Santa Barbara get $6 million to help estuaries
7. Future uses of MicroElectricalMechanical (MEM) systems to be featured at Santa Clara show
8. USGS Scientists To Speak On Rare Plants And Invasive Species At Santa Barbara Symposium
9. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
10. Dupont donates patents to UCSD
11. Procter & Gamble donates proprietary "super aspirin" technology to Vanderbilt University

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... , ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, ... list is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions ... reported three-year revenue growth of 71 percent. , The Inc. 5000 list represents ...
(Date:8/21/2020)... ... 2020 , ... NDA Partners Chairman Carl Peck, MD ... expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical investigator ... career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and anti-infective ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the Centers ... making them the first Wharton’s jelly allografts to be assigned a Q code and ... are the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 30, ... ... of cloud-based software for the life sciences industry, today announced the release ... platform designed specifically for Medical Science Liaisons (MSLs) and other field medical ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/10/2020)... Mass. (PRWEB) , ... July 09, 2020 , ... ... approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., ... team and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. ...
Breaking Biology Technology:
Cached News: